NICE joins institute, signaling next step in implementing RWE into cost-effectiveness analysis

NICE is taking the next step in applying real-world evidence to its technology appraisal methodology by joining the GetReal Institute, a public-private partnership that aims to facilitate the adoption of real-world evidence into healthcare decision-making in Europe.

The National Institute for Health and Care Excellence is in the midst of a major overhaul in how it appraises the cost-effectiveness of new medicines. Part of the new methodology is a willingness to use other data sources, including RWE, as a way to mitigate the uncertainty inherent in data from randomized controlled trials. ...